Stay updated on Peri-Op Checkpoint Inhibition+Cryoablation in TNBC Clinical Trial
Sign up to get notified when there's something new on the Peri-Op Checkpoint Inhibition+Cryoablation in TNBC Clinical Trial page.

Latest updates to the Peri-Op Checkpoint Inhibition+Cryoablation in TNBC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has been updated to include new information about the study on breast cancer treatments, specifically mentioning the drugs Ipilimumab and Nivolumab, and the involvement of various collaborators. The previous detailed description of the study's purpose and methodology has been removed.SummaryDifference36%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Peri-Op Checkpoint Inhibition+Cryoablation in TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Peri-Op Checkpoint Inhibition+Cryoablation in TNBC Clinical Trial page.